Finance

Lists
SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
$ 7.08
0.00%
(0.00) 1D
10-р сарын 1, 14:50:24 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHPMY...
Mkt. cap
64.55 тэрбум
Avg. vol.
116.00
Volume
0.00
52-wk high
$ 8.23
52-wk low
$ 6.41
Beta
0.58
Shares outstanding
183.81 сая
No. of employees
49 мян
Mkt. cap
64.55 тэрбум
Avg. vol.
116.00
Volume
0.00
52-wk high
$ 8.23
52-wk low
$ 6.41
Beta
0.58
Shares outstanding
183.81 сая
No. of employees
49 мян
News stories
From web sources and news partners
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holdings ADR
CEO-
Employees48.6 мян
Founded1994 оны 1-р сарын 18
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
73.48 тэрбум
68.51 тэрбум
75.26 тэрбум
72.21 тэрбум
Cost of goods sold
66.03 тэрбум
60.55 тэрбум
67.17 тэрбум
64.09 тэрбум
Cost of revenue
66.03 тэрбум
60.55 тэрбум
67.17 тэрбум
64.09 тэрбум
Research and development expenses
556.53 сая
824.53 сая
468.22 сая
502.64 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.70 тэрбум
4.97 тэрбум
4.59 тэрбум
4.65 тэрбум
Operating expense
5.58 тэрбум
5.91 тэрбум
5.47 тэрбум
5.55 тэрбум
Total operating expenses
71.60 тэрбум
66.47 тэрбум
72.63 тэрбум
69.64 тэрбум
Operating income
1.88 тэрбум
2.04 тэрбум
2.63 тэрбум
2.57 тэрбум
Other non operating income
-84.84 сая
-63.65 сая
-47.88 сая
-7.43 сая
EBT including unusual items
1.48 тэрбум
1.52 тэрбум
2.42 тэрбум
3.21 тэрбум
EBT excluding unusual items
1.61 тэрбум
1.44 тэрбум
2.27 тэрбум
3.03 тэрбум
Income tax expense
485.91 сая
534.14 сая
569.09 сая
720.64 сая
Effective tax rate
32.89%
35.10%
23.52%
22.43%
Other operating expenses
129.62 сая
271.29 сая
132.16 сая
186.62 сая
Net income
688.20 сая
577.49 сая
1.42 тэрбум
2.09 тэрбум
Net profit margin
0.94%
0.84%
1.88%
2.89%
Earnings per share
-
-
-
-
Interest and investment income
206.57 сая
-
38.70 сая
873.52 сая
Interest expense
-393.02 сая
-470.36 сая
-347.64 сая
-358.39 сая
Net interest expenses
-186.45 сая
-470.36 сая
-308.94 сая
515.13 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
2.26 тэрбум
2.54 тэрбум
3.12 тэрбум
3.07 тэрбум
Gain or loss from assets sale
39.99 сая
-157.15 сая
-
-179.70 сая
AI content may include mistakes. Learn more
Google аппс